MedPath

A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies

Completed
Conditions
Kidney Transplantation
Graft Rejection
Registration Number
NCT00498095
Lead Sponsor
Hospital Authority, Hong Kong
Brief Summary

Patients who had received kidney transplantation may suffer from rejection. Recently, positive staining for C4d in kidney biopsies of malfunctioning transplant kidney is increasingly recognized as an important prognostic indicator of poorer long-term kidney outcome. Data is, however, lacking in Hong Kong.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • All renal allograft biopsies performed in Princess Margaret Hospital (PMH) during the period 1st April 2003 to 31st August 2005 for unexplained acute renal dysfunction (Creatinine rise from baseline by ≥ 20%) or delayed graft function in the immediate post-transplantation period were included in the study. Both cadaveric and living-donor transplant allografts were included.
Exclusion Criteria
  • patients who were < 18 years' old at the time of renal biopsy or whose records were so incomplete that preclude meaningful analysis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Princess Margaret Hospital

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath